Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 186,523 | 191,214 | 182,394 | 171,836 | 178,105 |
| Cost of Goods | 99,875 | 89,273 | 87,228 | 81,736 | 81,965 |
| Gross Profit | 86,648 | 101,941 | 95,166 | 90,100 | 96,140 |
| Operating Expenses | 42,379 | 45,166 | 40,177 | 42,826 | 43,125 |
| Operating Income | 45,144 | 57,048 | 55,217 | 48,010 | 53,980 |
| Interest Expense | 6,425 | 6,698 | 8,609 | 8,611 | 9,456 |
| Other Income | 5,243 | -2,667 | 3,635 | 7,904 | -3,684 |
| Pre-tax Income | 43,962 | 47,683 | 50,243 | 47,303 | 40,840 |
| Income Tax | 5,998 | 7,254 | 12,294 | 4,126 | 4,673 |
| Net Income Continuous | 37,964 | 40,429 | 37,949 | 43,177 | 36,167 |
| Net Income | $37,964 | $40,429 | $37,949 | $43,177 | $36,167 |
| EPS Basic Total Ops | 0.79 | 0.83 | 0.77 | 0.90 | 0.76 |
| EPS Basic Continuous Ops | 0.79 | 0.83 | 0.78 | 0.90 | 0.76 |
| EPS Diluted Total Ops | 0.74 | 0.78 | 0.73 | 0.81 | 0.70 |
| EPS Diluted Continuous Ops | 0.74 | 0.78 | 0.73 | 0.81 | 0.69 |
| EPS Diluted Before Non-Recurring Items | 0.83 | 0.87 | 0.85 | N/A | N/A |
| EBITDA(a) | $59,304 | $71,192 | $70,801 | $63,121 | $69,718 |